Evidence map›Paper›PMID 38124459›Full record

ArticleESC heart failure2024

Incidence and predictors of heart failure with improved ejection fraction category in a HFrEF patient population.

Balázs Solymossi, Balázs Muk, Róbert Sepp, Tamás Habon, Attila Borbély, Krisztina Heltai, Zsuzsanna Majoros, Zoltán Járai, Dénes Vágány, Ákos Szatmári and 3 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in ESC heart failure, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
3.5field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 9 institutions in 4 countries.

Balázs SolymossiGottsegen National Cardiovascular Center, Budapest, Hungary.
Balázs MukGottsegen National Cardiovascular Center, Budapest, Hungary.
Róbert SeppDivision of Non-Invasive Cardiology, Department of Internal Medicine, University of Szeged, Szeged, Hungary.
Tamás HabonDivision of Cardiology, First Department of Medicine, Medical School, University of Pécs, Pécs, Hungary.
Attila BorbélyDivision of Cardiology, Department of Cardiology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
Krisztina HeltaiHeart and Vascular Center, Semmelweis University, Budapest, Hungary.
Zsuzsanna MajorosDepartment of Cardiology, Central Hospital of Northern Pest-Military Hospital, Budapest, Hungary.
Zoltán JáraiSouth-Buda Center Hospital, St Imre University Teaching Hospital, Budapest, Hungary.
Dénes VágányDepartment of Cardiology, Central Hospital of Northern Pest-Military Hospital, Budapest, Hungary.
Ákos SzatmáriCardiology Outpatient Clinic, Institute for Aviation Medicine, Military Fitness, and Medicine, Hungarian Defence Forces, Kecskemét, Hungary.
Erzsébet SziliczeiFejér County Szent György University Teaching Hospital, Székesfehérvár, Hungary.
Fanni Bánfi-BacsárdiGottsegen National Cardiovascular Center, Budapest, Hungary.
Noémi NyolczasGottsegen National Cardiovascular Center, Budapest, Hungary.
Gottsegen National Cardiovascular Center · HUMilitary Hospital · PKBuda Health Center · HUFejér Megyei Szent György Egyetemi Oktató Kórház · HUSemmelweis University · HUUniversity of Debrecen · HUUniversity of Pecs · HUUniversity of Szeged · HUWojskowy Instytut Medycyny Lotniczej · PL

Funding

Hungarian Society of Cardiology
6 · The paper itself

Abstract

aimsThe aim of the study was to assess the incidence and predictive factors of the development of heart failure with improved ejection fraction (HFimpEF) category during a 1 year follow-up period in a heart failure with reduced ejection fraction (HFrEF) patient population managed in a heart failure outpatient clinic. METHODS AND

resultsThe study evaluated data from patients enrolled in the Hungarian Heart Failure Registry (HHFR). The incidence and predictive factors of the development of the HFimpEF category after 1 year follow-up were assessed in the group of patients who had HFrEF at baseline. We evaluated the incidence and predictors of the development of HFimpEF after a 1 year follow-up in relation to time since diagnosis of HFrEF in patients diagnosed within 3 months, between 3 months and 1 year, and beyond 1 year. The predictive factors of the development of HFimpEF were analysed using univariate and multivariate logistic regression analysis. Of the 833 HFrEF patients enrolled in the HHFR, the development of HFimpEF was observed in 162 patients (19.5%) during 1 year follow-up. In the whole patient population, independent predictors of the development of HFimpEF were female gender [odds ratio (OR): 1.73; 95% confidence interval (CI): 1.01-2.96; P < 0.05], non-ischaemic aetiology (OR: 1.95; 95% CI: 1.15-3.30; P < 0.05), and left ventricular end-diastolic diameter (LVEDD) <60 mm (OR: 2.04; 95% CI: 1.18-3.51; P < 0.05). The 1 year incidence of HFimpEF decreased in relation to time since diagnosis of HFrEF. The incidence of HFimpEF was 27.1% in patients diagnosed within 3 months, 18.4% in patients diagnosed between 3 months and 1 year, and 12.2% in patients diagnosed beyond 1 year. Non-ischaemic aetiology (OR: 4.76; 95% CI: 1.83-12.4; P < 0.01) and QRS width (OR: 0.81; 95% CI: 0.71-0.94; P < 0.01) for patients diagnosed within 3 months, LVEDD (OR: 0.54; 95% CI: 0.32-0.90; P < 0.05) and left atrial diameter ≤45 mm (OR: 5.44; 95% CI: 1.45-20.4; P < 0.05) for patients diagnosed between 3 months and 1 year, and LVEDD < 67 mm (OR: 2.71; 95% CI: 1.07-6.88; P < 0.05) for patients diagnosed beyond 1 year were found to be independent predictive factors.

conclusionsIn our study, in this HFrEF patient population managed in a heart failure outpatient clinic, the 1 year incidence of HFimpEF was found to be ~20%. The 1 year incidence of HFimpEF decreased in relation to time since diagnosis of HFrEF. The most important predictors of the development of HFimpEF were female sex, non-ischaemic aetiology, narrower QRS width, and smaller diameter of the left ventricle and left atrium.

Indexed as

Heart FailureFemaleHumansIncidenceMalePrognosisRisk FactorsStroke VolumeHeart failure with improved ejection fractionIncidencePredictive factorsReverse remodelling

Identifiers

PMID38124459
PMCPMC10966271
OpenAlexW4390055253

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.